SectorBiological Technology
Established Date--
Listing Date04/02/2022
ExchangeNASDAQ Stock Exchange
Full-time Employees163
Fiscal Year Ends31/12
Security TypeCommon stock
Office address800 Bridge Parkway, Redwood City, CA 94065
Business
IntroductionArcellx, Inc., was incorporated in Delaware in December 2014. They are a clinical-stage biotechnology company reimagining cell therapy by developing innovative immunotherapies for patients with cancer and other incurable diseases. Their new synthetic binding scaffold D-Domain aims to overcome the limitations of traditional chimeric antigen receptor T cells.
